HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    


Top Stocks Set to Outperform
Over the Next 1 to 3 Months.

Click for your free picks >>

Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

DEPO: Depomed Inc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
DEPOMED INC (NASD)
DEPO 3.29 -0.01 (-0.30%) Vol.  353,106 16.00 CST

Nov 23, 2009 Depomed (DEPO) Bearish Technical Alert - Trend Down 20.9%
Nov 19, 2009 BiomedReports: News and FDA Updates for Depomed (NASDAQ:DEPO), Exelixis (Nasdaq:EXEL), PPD (NASDAQ:PPDI)
Nov 18, 2009 Depomed Promotes William Callahan to Vice President of Operations
Nov 17, 2009 Depomed Down 22% Since SmarTrend's Sell Recommendation
Nov 16, 2009 Depomed Ranked #13 on Deloitte's Technology Fast 500(TM)
Nov 10, 2009 Stock research report available on Depomed (NASDAQ:DEPO) from SmarTrend Analytics
Nov 10, 2009 Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA(R)
Nov 03, 2009 Depomed to Present at Merriman Curhan Ford's Investor Summit 2009
Nov 02, 2009 Depomed Down 26% Since SmarTrend's Sell Recommendation
Oct 30, 2009 BiomedReports: News and FDA Updates for Depomed (NASDAQ:DEPO), Perrigo (Nasdaq:PRGO), Transgenomic (OTC:TBIO)
Oct 27, 2009 Depomed Down 20.1% Since SmarTrend's Sell Recommendation
Oct 22, 2009 Depomed, Inc. to Announce Third Quarter 2009 Financial Results on October 29, 2009
Oct 22, 2009 Depomed Announces Delivery of First Formulation to Covidien and Receipt of $500,000 Milestone Payment
Oct 19, 2009 Depomed (DEPO) Bearish Technical Alert - Trend Down 14.5%
Oct 13, 2009 BUYINS.NET: DepoMed (DEPO) Daily Short Sale Trading Volume Through 10-12-09
 
ZACKS COMMENTARY FOR DEPO
Nov 02, 2009 Zacks Equity Research: Report for DEPO
Oct 06, 2009 Bull of the Day: Depomed, Inc. (DEPO)
Jul 22, 2009 Zacks Blog: Merck Deal Provides Nice Upside For Depomed
Jun 25, 2009 Zacks Blog: Initiating DepoMed with a Buy
Jun 19, 2009 Zacks Blog: An Update on Santarus

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research